| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.40B | 70.90B | 64.56B | 57.83B | 47.72B | 43.99B |
| Gross Profit | 53.41B | 50.08B | 46.59B | 42.11B | 34.60B | 31.34B |
| EBITDA | 7.38B | 6.77B | 4.93B | 2.49B | -1.19B | -282.83M |
| Net Income | 1.85B | 2.54B | 969.52M | 416.54M | -4.71B | -8.06B |
Balance Sheet | ||||||
| Total Assets | 69.35B | 71.46B | 49.43B | 48.80B | 48.02B | 55.81B |
| Cash, Cash Equivalents and Short-Term Investments | 13.85B | 14.25B | 16.66B | 15.73B | 15.64B | 15.02B |
| Total Debt | 22.56B | 23.00B | 6.02B | 6.04B | 6.05B | 8.00B |
| Total Liabilities | 38.64B | 40.61B | 19.28B | 18.45B | 16.87B | 18.13B |
| Stockholders Equity | 30.72B | 30.86B | 30.15B | 30.35B | 31.15B | 37.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.22B | 2.80B | 1.88B | 4.73B | -5.62B |
| Operating Cash Flow | 0.00 | 5.75B | 5.07B | 3.51B | 5.59B | -4.16B |
| Investing Cash Flow | 0.00 | -22.75B | -2.80B | -2.15B | -990.78M | -2.37B |
| Financing Cash Flow | 0.00 | 14.58B | -1.34B | -1.27B | -3.97B | 6.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥134.20B | 14.74 | ― | 2.09% | 5.78% | 10.26% | |
70 Outperform | ¥134.90B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
68 Neutral | ¥140.83B | 19.06 | ― | 1.88% | 16.70% | -0.37% | |
66 Neutral | ¥145.33B | 22.93 | 9.66% | 1.17% | 8.16% | -6.01% | |
63 Neutral | ¥750.98B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥64.18B | 17.62 | ― | 1.95% | 23.52% | -13.42% |